Basilea Pharmaceutica AG

Direct answer

Basilea Pharmaceutica AG is publicly traded on SIX under the ticker BSLN.SW.

Basilea Pharmaceutica AG operates as a commercial-stage biopharmaceutical enterprise, concentrating its efforts on inventing and advancing treatments to address critical unmet medical needs within the therapeutic fields of oncology and anti-infectives. Its commercialized offerings include Cresemba, an azole antifungal drug available in both intravenous and oral formulations, utilized for managing invasive...

Can you invest in Basilea Pharmaceutica AG?

Yes. Basilea Pharmaceutica AG trades publicly on SIX as BSLN.SW.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Basilea Pharmaceutica AG

Detailed equity research is provided by MarketSnap.